Diwakar Davar, M.D. – FDA Inspection, Oct 19, 2023

Record Details

This FDA Inspection record concerns Diwakar Davar, M.D., with an inspection on October 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Diwakar Davar, M.D.
Inspection Date: October 19, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Cynthia L. Rakestraw (FDA Associated Person)

View Company Profile

ID · 55fe1c49-17ea-48c6-94b2-223c36736a81

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1220610
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.66Initial and continuing review
21 CFR 312.66Changes in research
21 CFR 312.66Changes in research

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Diwakar Davar, M.D.

FDA Inspection

Diwakar Davar, M.D.October 19, 2023